EMMAUS LIFE SCIENCES, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $526.8K | $1.8M |
| Jun 2017 | — | $-953.1K | $409.3K |
| Sep 2017 | — | $4.5M | $5.4M |
| Nov 2017 | $555.0K | — | — |
| Dec 2017 | $559.7K | $18.3M | $2.7M |
| Mar 2018 | $569.0K | $1.8M | $2.4M |
| Jun 2018 | $578.4K | $3.1M | $2.6M |
| Sep 2018 | $587.7K | $4.0M | $3.3M |
| Oct 2018 | $13.6M | — | — |
| Dec 2018 | $597.1K | $-21.7M | $3.9M |
| Mar 2019 | $606.5K | $-32.3M | $2.2M |
| Jun 2019 | $615.8K | $-43.2M | $2.9M |
| Sep 2019 | $19.3M | $-12.2M | $1.3M |
| Dec 2019 | — | $-11.1M | $1.8M |
| Mar 2020 | $16.3M | $-4.7M | $2.2M |
| Jun 2020 | $17.1M | $-14.0M | $1.0M |
| Sep 2020 | $17.5M | $-6.4M | $4.9M |
| Dec 2020 | $15.3M | $-5.2M | $2.5M |
| Mar 2021 | $22.3M | $-12.7M | $3.8M |
| Jun 2021 | $22.5M | $-9.4M | $1.7M |
| Sep 2021 | $22.8M | $-15.1M | $2.3M |
| Dec 2021 | $22.3M | $-21.5M | $2.3M |
| Mar 2022 | $24.3M | $-22.3M | $813.0K |
| Jun 2022 | $27.0M | $-34.6M | $982.0K |
| Sep 2022 | $29.4M | $-37.6M | $1.2M |
| Dec 2022 | $30.4M | $-34.1M | $2.0M |
| Mar 2023 | $32.2M | $-37.4M | $1.8M |
| Jun 2023 | $31.3M | $-35.0M | $1.4M |
| Sep 2023 | $32.5M | $-36.3M | $1.5M |
| Dec 2023 | $30.6M | $-47.8M | $2.5M |
| Mar 2024 | $29.4M | $-53.6M | $1.7M |
| Jun 2024 | $29.4M | $-57.0M | $1.5M |
| Sep 2024 | $29.3M | $-53.8M | $1.3M |
| Dec 2024 | $29.0M | $-56.5M | $1.4M |
| Mar 2025 | $29.0M | $-58.6M | $1.3M |
| Jun 2025 | $29.7M | $-55.7M | $886.0K |
| Sep 2025 | $29.1M | $-59.5M | $293.0K |
| Dec 2025 | $27.1M | $-63.6M | $2.1M |
| Mar 2026 | $26.6M | $-67.9M | $1.1M |
| Jun 2026 | $25.0M | $-66.2M | $2.8M |